Last updateWed, 13 Jan 2021 10am

Back You are here: Inicio Biology & biomedicine

Low cost and reusable wearable sensors

Scientists at the CSIC have developed new portable and non-invasive sensors for monitoring biomarkers such as glucose, lactate or alcohol. They are based on wireless electro chromic and electrochemical sensors, and they can be used to detect metabolites in biological fluids, either human fluids (sweat, urine…) or in fluids derived from food products (e.g., leaking).

Read more ...

Modulating compounds of KChIP2 and its use for the treatment of cardiovascular pathologies

CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2protein. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.

Read more ...

Preclinical trial with efavirenz for the treatment of Niemann-Pick C disease

A team of scientists from the Centro de Biología Molecular Severo Ochoa (CMBSO-CSIC) has developed a new treatment for the Niemann-Pick disease type C (NPC) based on the drug efavirenz. The study is at the preclinical stage.

Read more ...

A metabolite from a drug against diabetes, a possible treatment for neurodegenerative diseases

MIN-102, a metabolite from a drug against diabetes, could be useful for treating some neurodegenerative diseases, as scientists think. To confirm this hypothesis, a project has been launched with the involvement of the CSIC’s Instituto de Investigaciones Biomédicas de Barcelona, the Hospital Universitari 'Sant Joan de Déu' and the University of Lleida. The research project is led by the company Mynorix Therapeutics.

Read more ...

A smart patch enables easy diagnosis of cystic fibrosis

A team led by CSIC scientists at the Institut de Microelectrònica de Barcelona (IMB-CNM), has developed a smart device based on a paper battery, which will make easier diagnosis of cystic fibrosis possible. This small device looks like a plaster and includes the sensing device and the energy source. Now, the scientific team is working for the clinical validation and transferring the device to the market.

Read more ...